Vaccine Court Denies Compensation in 2016 Flu Shot Case, Finds No Causation
### Flu Shot Fails Vaccine Court Causation Test
A U.S. Court of Federal Claims special master rejected Timothy Williams’ claim that a 2016 flu vaccine triggered his neurological woes, ruling no compensation under the National Vaccine Injury Compensation Program. Petitioner alleged the shot caused myasthenia gravis (MG), chronic inflammatory demyelinating polyneuropathy (CIDP), or inflammatory polyradiculopathy—but the court sided with evidence pointing to preexisting MG, not vaccine harm. This no-payout decision reinforces the high bar for proving “caused-in-fact” vaccine injuries, signaling to markets that government-backed vaccine programs won’t easily bend to unproven claims.
Williams filed in 2019, blaming his flu shot for debilitating fatigue, weakness, vision issues, and swallowing problems emerging days later, amid prior back pain and radiculopathy. He amended to include inflammatory polyradiculopathy after his expert, neuroimmunologist Lawrence Steinman, pushed it over MG or CIDP. Government experts—neurologist Raymond Price and immunologist John Bates—countered with records showing symptoms predated the shot, negative MG antibody tests notwithstanding, and EMG evidence of chronic, inactive polyradiculopathy from spine degeneration, not fresh inflammation. After a two-day hearing, Williams dropped his MG causation claim; the master ruled MG fits best—bulbar symptoms, fatigability, Mestinon response all classic—while polyradiculopathy was longstanding and mechanical. No causation analysis needed: Williams loses, gets nothing, case dismissed for lack of proof.
In plain terms, vaccine court demands “preponderance” evidence—more likely than not—that the shot was a substantial cause, via medical theory, logical sequence, and timing (Althen test). Here, judges ignored table presumptions (flu shots don’t list these injuries) and tore apart petitioner’s off-table theory: tests ruled out CIDP, literature like Doppler et al. didn’t match, and docs treated like MG without proving vaccine link. Pre-vax fatigue and pain undercut “but-for” causation; sympathy noted, but no win without solid proof.
Crypto markets yawn—this vaccine ruling has zero direct tie to SEC v. Ripple, Coinbase, or CFTC commodity fights, but it spotlights regulatory rigor in proving “cause” amid liability shields. No shift in SEC/CFTC turf wars over token classification or DeFi rules; exchanges like Binance or Kraken unaffected, as vaccine precedent won’t sway Howey test or stablecoin scrutiny. Decentralization fans might cheer the government’s win on scientific proof burdens, mirroring resistance to hasty crypto regs, but trader sentiment stays neutral—no volatility spike, just a reminder that courts demand data over anecdotes. Stablecoin issuers dodge any ripple (pun intended).
Vaccine claims face brutal scrutiny—crypto innovators, take note on proving utility before regulators pounce.
